Follow
RAJESH SINGH
Title
Cited by
Cited by
Year
Nanoparticle-based targeted drug delivery
R Singh, JW Lillard Jr
Experimental and molecular pathology 86 (3), 215-223, 2009
34282009
Challenges in liver cancer and possible treatment approaches
D Anwanwan, SK Singh, S Singh, V Saikam, R Singh
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1873 (1), 188314, 2020
12042020
Understanding the mechanism of bacterial biofilms resistance to antimicrobial agents
S Singh, SK Singh, I Chowdhury, R Singh
The open microbiology journal 11, 53, 2017
7132017
Past, present, and future technologies for oral delivery of therapeutic proteins
R Singh, S Singh, JW Lillard
Journal of pharmaceutical sciences 97 (7), 2497-2523, 2008
2382008
Resveratrol induces cell cycle arrest and apoptosis with docetaxel in prostate cancer cells via a p53/p21WAF1/CIP1 and p27KIP1 pathway
SK Singh, S Banerjee, EP Acosta, JW Lillard, R Singh
Oncotarget 8 (10), 17216, 2017
2342017
Drug delivery approaches for breast cancer
SK Singh, S Singh, JW Lillard Jr, R Singh
International journal of nanomedicine, 6205-6218, 2017
2152017
Inflammation, immunity, and cancer
R Singh, MK Mishra, H Aggarwal
Mediators of inflammation 2017, 2017
2022017
CCR5/CCL5 axis interaction promotes migratory and invasiveness of pancreatic cancer cells
SK Singh, MK Mishra, IEA Eltoum, S Bae, JW Lillard, R Singh
Scientific reports 8 (1), 1-12, 2018
1822018
Morphological characterization of very small embryonic‐like stem cells (VSELs) by ImageStream system analysis
EK Zuba‐Surma, M Kucia, A Abdel‐Latif, B Dawn, B Hall, R Singh, ...
Journal of cellular and molecular medicine 12 (1), 292-303, 2008
1442008
miR 488* inhibits androgen receptor expression in prostate carcinoma cells
K Sikand, JE Slaibi, R Singh, SD Slane, GC Shukla
International Journal of Cancer 129 (4), 810-819, 2011
1432011
CXCR3 axis: role in inflammatory bowel disease and its therapeutic implication
UP Singh, C Venkataraman, R Singh, JW Lillard
Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug …, 2007
1302007
Reversal of drug resistance by planetary ball milled (PBM) nanoparticle loaded with resveratrol and docetaxel in prostate cancer
SK Singh, JW Lillard Jr, R Singh
Cancer letters 427, 49-62, 2018
1062018
Combinatorial effect of curcumin with docetaxel modulates apoptotic and cell survival molecules in prostate cancer
S Banerjee, SK Singh, I Chowdhury, JW Lillard Jr, R Singh
Frontiers in bioscience (Elite edition) 9, 235, 2017
1032017
Serum CXCL13 positively correlates with prostatic disease, prostate-specific antigen and mediates prostate cancer cell invasion, integrin clustering and cell adhesion
S Singh, R Singh, PK Sharma, UP Singh, SN Rai, LWK Chung, ...
Cancer letters 283 (1), 29-35, 2009
1022009
CCL25 mediates migration, invasion and matrix metalloproteinase expression by breast cancer cells in a CCR9-dependent fashion
C Johnson-Holiday, R Singh, E Johnson, S Singh, CR Stockard, ...
International journal of oncology 38 (5), 1279-1285, 2011
972011
Nanoparticles for delivery of active agents
JW Lillard, R Singh, S Singh
US Patent 8,568,784, 2013
962013
CXCL13 mediates prostate cancer cell proliferation through JNK signalling and invasion through ERK activation
CP El‐Haibi, R Singh, PK Sharma, S Singh, JW Lillard Jr
Cell proliferation 44 (4), 311-319, 2011
902011
Chemokines: key players in cancer progression and metastasis
R Singh, JW Lilladr Jr, S Singh
Frontiers in bioscience (Scholar edition) 3, 1569, 2011
852011
Clinical and biological significance of CXCR5 expressed by prostate cancer specimens and cell lines
S Singh, R Singh, UP Singh, SN Rai, KR Novakovic, LWK Chung, ...
International journal of cancer 125 (10), 2288-2295, 2009
782009
High‐fat diet activates pro‐inflammatory response in the prostate through association of Stat‐3 and NF‐κB
E Shankar, EV Vykhovanets, OV Vykhovanets, GT MacLennan, R Singh, ...
The Prostate 72 (3), 233-243, 2011
752011
The system can't perform the operation now. Try again later.
Articles 1–20